Two‐Pronged Intracellular Co‐Delivery of Antigen and Adjuvant for Synergistic Cancer Immunotherapy
Junli Meng,Peisen Zhang,Qizhe Chen,Zihua Wang,Yuan Gu,Jie Ma,Wang Li,Chen Yang,Yuanyuan Qiao,Yi Hou,Lihong Jing,Yong Wang,Zi Gu,Lichong Zhu,Haozhen Xu,Xueguang Lu,Mingyuan Gao
DOI: https://doi.org/10.1002/adma.202202168
IF: 29.4
2022-04-24
Advanced Materials
Abstract:Nanovaccines have emerged as promising alternatives or complements to conventional cancer treatments. Despite the progresses, specific co‐delivery of antigen and adjuvant to their corresponding intracellular destinations for maximizing the activation of antitumor immune responses remains a challenge. Herein, we developed a lipid‐coated iron oxide nanoparticle as nanovaccine (IONP‐C/O@LP) that could co‐deliver peptide antigen and adjuvant (CpG DNA) into cytosol and lysosomes of dendritic cells (DCs) through both membrane fusion and endosome‐mediated endocytosis. Such two‐pronged cellular uptake pattern enabled IONP‐C/O@LP to synergistically activate immature DCs. Iron oxide nanoparticle also exhibited adjuvant effects by generating intracellular reactive oxygen species, which further promoted DC maturation. IONP‐C/O@LP accumulated in the DCs of draining lymph nodes effectively increased the antigen‐specific T cells in both tumor and spleen, inhibited tumor growth, and improved animal survival. Moreover, we have demonstrated that this nanovaccine is a general platform of delivering clinically relevant peptide antigens derived from human papilloma virus 16 to trigger antigen‐specific immune responses in vivo.This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology